Leukopak®, Frozen

In stock
Category: Research Products
Select SKU Size / Day Price
LE010C 10 billion TNCs $3,500 USD
Questions about shipping? See Shipping Info
Questions? Contact Sales:
Contact Us
Product Description

Leukopaks are collected from healthy human donors, tested negative for HBV, HCV, and HIV, using the Spectra Optia® Apheresis System, where cell-rich mononuclear cells are extracted using a continuous flow method directly into a sterile collection bag containing the anticoagulant ACD-A. Leukopaks are quickly frozen in a medium containing the cryoprotective agent DMSO (10%) using a controlled rate freezer to ensure maximum viability. Up to 12 Leukopak collections can be performed on the same donor in a given year, providing an ample amount of PBMCs for large-scale experiments and research studies. Additionally, 200-300mL of plasma can be collected at the time of the donor draw. 

• Enriched PBMCs
• 0.1-0.2% CD34+ cells
• Low hematocrit
• Low granulocytes

Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.

Custom Orders

Design the right Leukopak for your research needs. View our custom orders to see what options we have available.

More Information
Species Human
Disease State Healthy
Cell and Tissue Source Peripheral Blood
Product Type Whole
Cell Type Mononuclear Cells
Donor Attributes HIV-, HepB-, HepC-
Viability ≥80% by Flow Cytometry
Format Frozen
Contains 10% DMSO
Anticoagulant ACD-A

Product Information Sheet

Certificate of Analysis

Material Safety Data Sheet

Hi, have questions?

A StemExpress Expert is happy to help!

Call 530.303.3828 or Contact Us